Air date: December 9, 2021
Andrea Gielen, ScD, ScM, Professor, Johns Hopkins Bloomberg School of Public Health
Mary Imboden, PhD, Director of Research, Health Enhancement Research Organization (HERO)
It did not come as a surprise when HERO research found strategic planning was associated with better health improvement outcomes. What does surprise us is that HERO studies continue to show that too few organizations have detailed written plans related to their employee health promotion initiatives. We will discuss community and workplace applications of the PRECEDE-PROCEED model, a planning framework that has been employed in over 1,000 health improvement studies and program implementations. This webinar coincides with the soon to be released new edition of one of the most seminal books in the health promotion profession: “Health Program Planning, Implementation, and Evaluation: Creating Behavioral, Environmental, and Policy Change.” In particular, this new edition recognizes fresh methods for reaching a greater diversity of communities and addresses the complex factors that influence population inequities, from biology to social and structural determinants.
We are proud to host Professor Andrea Gielen, a Senior Editor of this new edition. Dr. Gielen is an expert in injury research and policy at Johns Hopkins Bloomberg School of Public Health. Her current research focuses on using mobile apps to communicate effective injury prevention messages as part of a comprehensive program, identifying effective sexual assault prevention programming and informed decision making about opioid prescribing.
Dr. Gielen will be joined by Dr. Mary Imboden, HERO’s Director of Research, who will explain how the HERO Scorecard fits into a strategic planning framework. Dr. Paul Terry, HERO Senior Fellow, will host this webinar. Dr. Terry co-authored the chapter on “Applications in Occupational Settings” for this Health Program Planning book’s new edition.
Andrea Gielen, ScD, ScM, is a professor and expert in injury research and policy at Johns Hopkins Bloomberg School of Public Health. Her research has spanned from the development and evaluation of community and clinic-based health promotion programs for women and children to the application of behavioral sciences to preventing childhood injury and violence against women. Her current research focuses on using mobile apps to communicate effective injury prevention messages as part of a comprehensive program, identifying effective sexual assault prevention programming and informed decision making about opioid prescribing. Dr. Gielen has won numerous public health honors including the Elizabeth Fries Health Education Award, CDC Foundation Distinguished Career Award, the American Public Health Association Award for Excellence, and she was named one of the “20 for 20” Distinguished Leaders in Injury Prevention by the Centers for Disease Control and Prevention.
Mary Imboden, PhD, is the Director of Research for HERO where she oversees the execution of the HERO research agenda. This includes providing oversight of the HERO Research Committee and consultation to HERO study committees. She also oversees the ongoing development and research of the HERO Health and Well-Being Best Practices Scorecard in Collaboration with Mercer © (HERO Scorecard), along with growth and management of the HERO Preferred Provider Network.
This webinar is available to members only.